Peptide Association

Insights

NewsBlog
Start free intake

DisclosurePeptide Association LLC is a for-profit company. We receive compensation from the clinical providers listed on this site. We are not an accrediting body, a licensing board, or a government-affiliated organization. See exactly how we make money.

The compound database

Peptide Database

264 therapeutic peptides with research summaries, clinical findings, and regulatory status. Every claim is cited.

FDA-approved
90
FDA-approved
Awaiting FDA
8
Awaiting FDA
No lawful pathway
166
No lawful pathway
1–5 of 5 · Hematology · FDA ApprovedClear filters
  1. 001

    Bivalirudin (Angiomax)

    A synthetic 20-amino acid peptide analog of hirudin that acts as a specific, reversible direct thrombin inhibitor, binding both fluid-phase and clot-bound…

    Hematology · FDA Approved · Intravenous

    FDA-approved
  2. 002

    Romiplostim (Nplate)

    A thrombopoietin (TPO) receptor agonist built as a peptibody: TPO-mimetic peptides fused to the Fc portion of human IgG1. It has a similar mechanism of action…

    Hematology · FDA Approved · Subcutaneous injection (weekly)

    FDA-approved
  3. 003

    Pegcetacoplan (Empaveli)

    A pegylated cyclic peptide that inhibits complement component C3 and C3b, acting upstream of C5 in the complement cascade. Because C5 inhibitors control…

    Hematology · FDA Approved · Subcutaneous infusion

    FDA-approved
  4. 004

    Peginesatide (Omontys)

    Peginesatide is a synthetic pegylated peptide-based erythropoiesis-stimulating agent that activates the erythropoietin receptor despite having no sequence…

    Hematology · FDA Approved · Intravenous, Subcutaneous injection

    FDA-approved
  5. 005

    Eltrombopag Peptide Mimetics

    Eltrombopag is an orally active, small-molecule, non-peptide thrombopoietin receptor agonist. Although it is not itself a peptide, it activates thrombopoietin…

    Hematology · FDA Approved · Oral

    FDA-approved

Index · all 264 peptides, A–Z

Important Medical Disclaimer

The information provided by the Peptide Association is for educational and informational purposes only and is not intended as a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of a qualified, licensed healthcare provider before beginning any peptide therapy, supplement regimen, or making changes to an existing treatment plan.

Peptide therapies discussed on this site may not be FDA-approved for all listed indications. Individual results vary. The Peptide Association does not prescribe, diagnose, or treat any medical condition. Clinicians in our network are independently licensed practitioners; the Association checks each clinician’s NPI record but does not employ or directly supervise these clinicians.

© 2026 The Peptide Association. All rights reserved. Content on this site is protected under applicable intellectual property laws. The Peptide Association is not a medical practice.